| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2403221 | Vaccine | 2012 | 1993 Pages |
Abstract
► Prophylactic HPV vaccines are safe, effective and widely implemented. ► Screening is by visual inspection, cytology, HPV DNA tests and disease biomarkers. ► New small molecule inhibitors and immunotherapies for HPV lesions are needed. ► Public education and advocacy for HPV R&D are communal responsibilities. ► Reduction of HPV diseases through stakeholder efforts will be a public health triumph.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Thomas R. Broker,